The ADMA-Metformin Hypothesis: Linking the Cardiovascular Consequences of the Metabolic Syndrome and Type 2 Diabetes

Publisher： Karger

E-ISSN： 1664-5502|1|4|211-219

ISSN： 1664-3828

Source： Cardiorenal Medicine, Vol.1, Iss.4, 2011-10, pp. : 211-219

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Possible Mechanisms of Local Tissue Renin-Angiotensin System Activation in the Cardiorenal Metabolic Syndrome and Type 2 Diabetes Mellitus

By  

Cardiorenal Medicine, Vol. 1, Iss. 3, 2011-07 ,pp. : 193-210

Karger

Access to resources Recommend Favorite

Renal Redox Stress and Remodeling in Metabolic Syndrome, Type 2 Diabetes mellitus, and Diabetic Nephropathy: Paying Homage to the Podocyte

By  

American Journal of Nephrology, Vol. 25, Iss. 6, 2005-10 ,pp. : 553-569

Karger

Access to resources Recommend Favorite

Risks of Metformin in Type 2 Diabetes and Chronic Kidney Disease: Lessons Learned from Taiwanese Data

By  

Nephron, Vol. 135, Iss. 2, 2016-10 ,pp. : 147-153

Karger

Access to resources Recommend Favorite

Fibrinolysis Defect in Long-Term Hemodialysis Patients with Type 2 Diabetes mellitus and Its Relation to Metabolic Disorders

By  

American Journal of Nephrology, Vol. 22, Iss. 5-6, 2002-10 ,pp. : 429-436

Karger

Access to resources Recommend Favorite

Characteristics, Cardiovascular Comorbidity and Medicines Management in Patients with Type 2 Diabetes and CKD: Results of the IRIDIEM Study

By  

Kidney and Blood Pressure Research, Vol. 33, Iss. 2, 2010-04 ,pp. : 119-128

Karger

Access to resources Recommend Favorite